FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229016989> ?p ?o ?g. }

• W4229016989 endingPage "102100" @default.
• W4229016989 startingPage "102100" @default.
• W4229016989 abstract "This meta-analysis was performed to evaluate the effect and safety of selexipag in the treatment of pulmonary hypertension and to explore the effect of selexipag on cardiac function indexes in PAH patients.Electronic databases, including the Cochrane Library, EMBASE, and PubMed databases, were searched. Endnote software X9 was used for study selection, and the Cochrane Risk of Bias Tool was used for literature screening and quality assessment. Data analysis was performed using RevMan 5.3 software, and GRADE was used to assess the evidence level.Ten studies were finally selected in accordance with the standard. A total of 10 papers were included. A total of 1322 patients were included, including 723 in the trial group and 599 in the control group. Patients with PAH treated with selexipag were included in the trial group, and patients with PAH treated with placebo were included in the control group. The results of the study showed that selexipag was effective in reducing mortality in patients (WMD=0.70, 95% CI: 0.53-0.94, P = 0.02). Selexipag effectively increased the 6-min walk distance (WMD=33.79, 95% CI: 2.69-64.90, P=0.03). Selexipag also effectively increased the 6-min distance between baseline and follow-up (WMD = 15.28, 95% CI: 7.76-22.80, P < 0.0001). Selexipag effectively reduced PVR (WMD = -230.96, 95% CI: 445.94 to -15.97, P = 0.04). Selexipag significantly reduced PVR between baseline and follow-up (WMD = -139.62, 95% CI: 215.32 to -63.91, P = 0.0003). The adverse reactions of selexipag were mild with headache, diarrhea and nausea reported as the main symptoms.Selexipag is a new drug with mild adverse reactions and is safe for the treatment of PAH. This drug significantly prolongs the level of 6MWD in PAH patients, reduces the fatality rate, improves WHO FC and reduces PVR. The effects of this drug on CI, mPAP, MRAP, SvO2 and other indicators still need to be further confirmed.CRD42021245557." @default.
• W4229016989 created "2022-05-08" @default.
• W4229016989 creator A5005435867 @default.
• W4229016989 creator A5016658530 @default.
• W4229016989 creator A5017230378 @default.
• W4229016989 creator A5031334510 @default.
• W4229016989 creator A5038199222 @default.
• W4229016989 creator A5040819519 @default.
• W4229016989 creator A5055611906 @default.
• W4229016989 creator A5070287856 @default.
• W4229016989 creator A5071773009 @default.
• W4229016989 creator A5084768117 @default.
• W4229016989 date "2022-02-01" @default.
• W4229016989 modified "2023-10-14" @default.
• W4229016989 title "Efficacy and safety of selexipag, an oral prostacyclin receptor agonist for the treatment of pulmonary hypertension: A meta-analysis" @default.
• W4229016989 cites W1840736932 @default.
• W4229016989 cites W2096352797 @default.
• W4229016989 cites W2102522559 @default.
• W4229016989 cites W2135510321 @default.
• W4229016989 cites W2136124268 @default.
• W4229016989 cites W2161450347 @default.
• W4229016989 cites W2278696749 @default.
• W4229016989 cites W2321522617 @default.
• W4229016989 cites W2553252503 @default.
• W4229016989 cites W2605453134 @default.
• W4229016989 cites W2619761992 @default.
• W4229016989 cites W2745759236 @default.
• W4229016989 cites W2891121766 @default.
• W4229016989 cites W2910609445 @default.
• W4229016989 cites W2913022745 @default.
• W4229016989 cites W2926135686 @default.
• W4229016989 cites W2939673088 @default.
• W4229016989 cites W2951563757 @default.
• W4229016989 cites W2970890961 @default.
• W4229016989 cites W2974971559 @default.
• W4229016989 cites W3000062577 @default.
• W4229016989 cites W3013479270 @default.
• W4229016989 cites W3081589912 @default.
• W4229016989 cites W3176651261 @default.
• W4229016989 doi "https://doi.org/10.1016/j.pupt.2021.102100" @default.
• W4229016989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34856365" @default.
• W4229016989 hasPublicationYear "2022" @default.
• W4229016989 type Work @default.
• W4229016989 citedByCount "2" @default.
• W4229016989 countsByYear W42290169892023 @default.
• W4229016989 crossrefType "journal-article" @default.
• W4229016989 hasAuthorship W4229016989A5005435867 @default.
• W4229016989 hasAuthorship W4229016989A5016658530 @default.
• W4229016989 hasAuthorship W4229016989A5017230378 @default.
• W4229016989 hasAuthorship W4229016989A5031334510 @default.
• W4229016989 hasAuthorship W4229016989A5038199222 @default.
• W4229016989 hasAuthorship W4229016989A5040819519 @default.
• W4229016989 hasAuthorship W4229016989A5055611906 @default.
• W4229016989 hasAuthorship W4229016989A5070287856 @default.
• W4229016989 hasAuthorship W4229016989A5071773009 @default.
• W4229016989 hasAuthorship W4229016989A5084768117 @default.
• W4229016989 hasConcept C126322002 @default.
• W4229016989 hasConcept C142724271 @default.
• W4229016989 hasConcept C204787440 @default.
• W4229016989 hasConcept C27081682 @default.
• W4229016989 hasConcept C2776478404 @default.
• W4229016989 hasConcept C71924100 @default.
• W4229016989 hasConcept C90924648 @default.
• W4229016989 hasConcept C95190672 @default.
• W4229016989 hasConceptScore W4229016989C126322002 @default.
• W4229016989 hasConceptScore W4229016989C142724271 @default.
• W4229016989 hasConceptScore W4229016989C204787440 @default.
• W4229016989 hasConceptScore W4229016989C27081682 @default.
• W4229016989 hasConceptScore W4229016989C2776478404 @default.
• W4229016989 hasConceptScore W4229016989C71924100 @default.
• W4229016989 hasConceptScore W4229016989C90924648 @default.
• W4229016989 hasConceptScore W4229016989C95190672 @default.
• W4229016989 hasLocation W42290169891 @default.
• W4229016989 hasLocation W42290169892 @default.
• W4229016989 hasOpenAccess W4229016989 @default.
• W4229016989 hasPrimaryLocation W42290169891 @default.
• W4229016989 hasRelatedWork W2015973236 @default.
• W4229016989 hasRelatedWork W2096351556 @default.
• W4229016989 hasRelatedWork W2283166834 @default.
• W4229016989 hasRelatedWork W2362237808 @default.
• W4229016989 hasRelatedWork W2374685850 @default.
• W4229016989 hasRelatedWork W2771482620 @default.
• W4229016989 hasRelatedWork W2787845637 @default.
• W4229016989 hasRelatedWork W4221084476 @default.
• W4229016989 hasRelatedWork W4315645414 @default.
• W4229016989 hasRelatedWork W2903040050 @default.
• W4229016989 hasVolume "72" @default.
• W4229016989 isParatext "false" @default.
• W4229016989 isRetracted "false" @default.
• W4229016989 workType "article" @default.